Live News Categoriesmarket

HLUNA.CO (HLUNA.CO) News

Track canonical SquawkNews coverage tagged to HLUNA.CO, HLUNA.CO. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol HLUNA.CO Asset market Sector Markets 90 days 1 Updated Sep 21, 2026, 10:13 AM UTC Open live news feed

M UBS upgrades Lundbeck to 'buy' on epilepsy drug conviction UBS upgraded H Lundbeck to "buy" from "neutral", citing strong conviction in its developing epilepsy drug bexicaserin, which it forecasts could offset patent expirations for its key drug Rexulti in 2029 and achieve $2 bi EQUITY | Sep 21, 2026, 10:13 AM UTC